Enlivex Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
72.1%projected annual EPS growth
Analyst Coverage
1analyst covering
Monitoring Framework
Key Performance Indicators
Allocetra Phase IIb Clinical Trial Enrollment QuarterlyTarget: Complete enrollment of patients with moderate-to-severe age-related symptomatic primary knee osteoarthritis
RAIN Token Treasury Holdings Monthly79.6BTarget: Maximize yield and strategic accumulation via option exercises
RAIN Token Treasury Valuation Monthly1.2BTarget: Sustained capital appreciation aligned with prediction market growth
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days before November 9, 2026
- RAIN Token Option ExpirationTrigger: December 31, 2027 expiration dateAction: Monitor intrinsic value and execute partial or full exercises of the option to acquire up to 271,372,418,179 RAIN tokens at $0.0033 per token
- On-chain Reputational and Manipulation AllegationsTrigger: Public warnings or investigations regarding Rain Protocol team addresses and on-chain activityAction: Assess impact on RAIN token liquidity, exchange listings, and treasury valuation
Research as of 20 Jun 2026